205 related articles for article (PubMed ID: 7046055)
1. The National Cancer Chemotherapy Program.
Frei E
Science; 1982 Aug; 217(4560):600-6. PubMed ID: 7046055
[TBL] [Abstract][Full Text] [Related]
2. The preclinical new drug research program of the National Cancer Institute.
Driscoll JS
Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
[TBL] [Abstract][Full Text] [Related]
3. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
4. The National Cancer Institute: cancer drug discovery and development program.
Grever MR; Schepartz SA; Chabner BA
Semin Oncol; 1992 Dec; 19(6):622-38. PubMed ID: 1462164
[TBL] [Abstract][Full Text] [Related]
5. History of the National Cancer Institute and the plant screening program.
Schepartz SA
Cancer Treat Rep; 1976 Aug; 60(8):975-7. PubMed ID: 791487
[No Abstract] [Full Text] [Related]
6. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
Goldin A; Venditti JM
Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
[No Abstract] [Full Text] [Related]
7. Oncology clinical trials.
Mellody P; Dehgan A
Case Manager; 1999; 10(3):73-5. PubMed ID: 11061127
[TBL] [Abstract][Full Text] [Related]
8. The National Cancer Institute's Natural Products Antineoplastic Development Program.
Douros J; Suffness M
Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
[TBL] [Abstract][Full Text] [Related]
9. The evolution of cancer chemotherapy.
Chabner BA
Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
[No Abstract] [Full Text] [Related]
10. Investigational trials of anticancer drugs: establishing safeguards for experimentation.
Chabner BA; Wittes R; Hoth D; Hubbard S
Public Health Rep; 1984; 99(4):355-60. PubMed ID: 6431482
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
12. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
[No Abstract] [Full Text] [Related]
13. The NCI Developmental Therapeutics Program.
Collins JM
Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
[No Abstract] [Full Text] [Related]
14. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
[TBL] [Abstract][Full Text] [Related]
15. The role of the National Cancer Institute in drug development.
Doroshow J
Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
[No Abstract] [Full Text] [Related]
16. Natural product drug discovery and development: the United States National Cancer Institute role.
Cragg GM
P R Health Sci J; 2002 Jun; 21(2):97-111. PubMed ID: 12166031
[No Abstract] [Full Text] [Related]
17. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
[No Abstract] [Full Text] [Related]
18. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
Goldin A; Venditti JM; Macdonald JS; Muggia FM; Henney JE; Devita VT
Eur J Cancer (1965); 1981 Feb; 17(2):129-42. PubMed ID: 6894902
[No Abstract] [Full Text] [Related]
19. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
20. The search for therapeutic cell controls by the chemotherapy program of the National Cancer Institute.
Carter SK
J Invest Dermatol; 1972 Jul; 59(1):128-38. PubMed ID: 4557098
[No Abstract] [Full Text] [Related]
[Next] [New Search]